All products from TargetMol are for Research Use Only. Not for Human or Veterinary or Therapeutic Use.
Biological Description
Description: Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM.
Targets&IC50: PI3K:3 nM, DNA-PK:16 nM, ATM:150 nM
In vitro: Mitomycin C, by inducing DNA interstrand crosslinks, physically blocks DNA replication, recombination, and RNA transcription. Mitomycin C potentiates TRAIL-induced apoptosis in HCT116 (p53-/-) colon cancer cells and sensitizes TRAIL-resistant colon cancer cells HT-29 to the cytokine by through JNK-independent upregulation of death receptors. [2] In different human cancer cell lines, such OVCAR-5 (ovary), HT-29 (colon), SK-N-MC (neuroblastoma), HEP-2 (liver), COLO-205 (colon), NIH-OVCAR-3 (ovary) and A-549 (lung) cells, Mitomycin C shows cytotoxic activity.
Chemical Properties
Molecular Weight: 428.437
Formula: C23H24O8
CAS No.: 19545-26-7
Storage & Solubility Information
Storage
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Solubility Information
Ethanol: 2.1 mg/mL (5 mM)), with gentle warming
DMSO: 21.4 mg/mL (50 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Catalog #: T6283
Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.